NCT05900076View on ClinicalTrials.gov

Technical Feasibility of the cfDNA Test for Non-invasive Cytogenetic Analysis of Early Miscarriages Versus the Gold Standard Microarray

CompletedOBSERVATIONAL
Enrollment

78

Participants

Timeline

Start Date

July 18, 2023

Primary Completion Date

July 19, 2024

Study Completion Date

July 19, 2024

Conditions
Spontaneous Miscarriage
Interventions
DIAGNOSTIC_TEST

Curettage for the evacuation of the product of conception

The product of conception taken during the intervention will be recovered at Day 1

Trial Locations (2)

69500

Hopital Femme-Mère-Enfant; service gynécologie/obstétrique, Bron

Hopital Femme-Mère-Enfant; service médecine de la reproduction, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER